![Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss - Journal of the Neurological Sciences Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2001344644/2005281661/gr1.jpg)
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss - Journal of the Neurological Sciences
![Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4f50ecfa-35e2-44b0-b777-cd31c8b5ed1c/sim5672-fig-0001-m.jpg)
Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library
![2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram 2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram](https://www.researchgate.net/publication/40798768/figure/fig7/AS:408360974340102@1474372251459/Relationship-between-a-surrogate-marker-and-true-outcome-adjusted-for-this-thesis-28.png)
2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
![Vaccines | Free Full-Text | V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers Vaccines | Free Full-Text | V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers](https://www.mdpi.com/vaccines/vaccines-07-00082/article_deploy/html/images/vaccines-07-00082-ag.png)
Vaccines | Free Full-Text | V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers
![Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01234-5/MediaObjects/12933_2021_1234_Fig1_HTML.png)
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
![Early ctDNA response to chemotherapy. A potential surrogate marker for overall survival - European Journal of Cancer Early ctDNA response to chemotherapy. A potential surrogate marker for overall survival - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0ff9cd7c-8e0e-41ab-af8b-52ed6abffc5e/gr1_lrg.jpg)
Early ctDNA response to chemotherapy. A potential surrogate marker for overall survival - European Journal of Cancer
![Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies - Journal of Hepatology Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d9bd2f34-af1d-47ee-a4c8-40705a297822/ga1_lrg.jpg)